Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

FDA Approvals

Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

FDA Approvals
AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that Lynparza (olaparib) has been approved in the European Union (EU) for patients with germline BRCA-mutated...

AstraZeneca’s Farxiga scores another FDA fast-track designation

FDA Approvals
AstraZeneca’s heart failure drug Farxiga has picked up a US FDA fast-track designation (FTD) in another indication as it continues to strengthen its position...

Boehringer Ingelheim gets European approval for additional indication for nintedanib in pulmonary fibrosis

FDA Approvals
Boehringer Ingelheim announced that the EC has approved an additional indication for nintedanib in adults for the treatment of other chronic fibrosing interstitial lung...

TREMFYA Approved by U.S. FDA as the First Selective Interleukin Inhibitor for Active Psoriatic Arthritis

FDA Approvals
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. FDA has approved TREMFYA for adult patients with active psoriatic arthritis (PsA),...

Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19

Drug Development
In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the launch of antiviral drug Favipiravir...

Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe

FDA Approvals
Kite, a Gilead Company announced it has received approval to implement a variation to the Yescarta® (axicabtagene ciloleucel) Marketing Authorization from the EMA for...

FDA Approves Merck’s RECARBRIO for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

FDA Approvals
Merck, known as MSD outside the United States and Canada, announced that the U.S. FDA has approved a supplemental New Drug Application (sNDA) for...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.